UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000046828
Receipt No. R000053407
Scientific Title Urinary eicosanoids and salivary stress hormones in patients with sleep-disordered breathing
Date of disclosure of the study information 2022/02/04
Last modified on 2022/04/07 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Urinary eicosanoids and salivary stress hormones in patients with sleep-disordered breathing
Acronym Urinary eicosanoids and salivary stress hormones in patients with sleep-disordered breathing
Scientific Title Urinary eicosanoids and salivary stress hormones in patients with sleep-disordered breathing
Scientific Title:Acronym Urinary eicosanoids in patients with sleep-disordered breathing
Region
Japan

Condition
Condition sleep disorder
Classification by specialty
Pneumology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Investigating the effects of sleep-disordered breathing on urinary eicosanoids and stress hormones during sleep
Basic objectives2 Others
Basic objectives -Others Development of non-invasive indicators
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Urinary eicosanoids
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients admitted for PSG who agreed to the purpose of this study
Key exclusion criteria Patients who are judged by the principal investigator to be unsuitable as subjects
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Hiroo
Middle name
Last name Wada
Organization Juntendo University
Division name Faculty of Medicine
Zip code 113-8431
Address 2-1-1 Hongo, Bunkyo, Tokyo
TEL 03-3813-3111
Email h-wada@juntendo.ac.jp

Public contact
Name of contact person
1st name Hiroo
Middle name
Last name Wada
Organization Juntendo University
Division name Faculty of Medicine
Zip code 113-8431
Address 2-1-1 Hongo, Bunkyo, Tokyo
TEL 03-3813-3111
Homepage URL
Email h-wada@juntendo.ac.jp

Sponsor
Institute Department of Public Health,
Juntendo University Graduate School of Medicine
Institute
Department

Funding Source
Organization Department of Public Health,
Juntendo University Graduate School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethical Review Board of Juntendo University
Address 2-1-1 Hongo, Bunkyo, Tokyo
Tel 03-3813-3111
Email N/A

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 02 Month 04 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2021 Year 07 Month 17 Day
Date of IRB
Anticipated trial start date
2022 Year 03 Month 01 Day
Last follow-up date
2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Study Design
Uncontrolled, open-label, exploratory clinical trial

Method of recruitment of subjects
Patients visiting the clinic who are willing to participate in this study and have permission to use the data

Management information
Registered date
2022 Year 02 Month 04 Day
Last modified on
2022 Year 04 Month 07 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053407